Patent details

Basic Information

Publication number:

EP2363113

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP111658241

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Enhanced immediate release formulations of topiramate

French Title of Invention:

Formulations à libération immédiate de topiramate améliorées

German Title of Invention:

Topiramat-Formulierungen für verstärkte unmittelbare Freisetzung

SPC Number:

Dates

Filing date:

04/12/2007

Grant date:

02/08/2017

EP Publication Date:

07/09/2011

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

02/08/2017

EP B1 Publication Date:

02/08/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

04/12/2017

Expiration date:

04/12/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

02/08/2017

 

 

Name:

Supernus Pharmaceuticals, Inc.

Address:

1550 East Gude Drive, Rockville, MD 20850, United States (US)

Inventor

1

Name:

Liang, Likan

Address:

United States (US)

2

Name:

Wang, Hua

Address:

United States (US)

3

Name:

Bhatt, Padmanabh

Address:

United States (US)

Priority

Priority Number:

872497 P

Priority Date:

04/12/2006

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/00; A61K 9/48; A61K 31/7048;

Publication

European Patent Bulletin

Issue number:

201731

Publication date:

02/08/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/04/2018	Outgoing Correspondence	1